1.0Gizmodo Australiahttps://gizmodo.com.auGizmodo Internationalhttps://gizmodo.com.au/author/gizmodointernational/New Cancer Therapy Leaves Three Deadrich600338<blockquote class="wp-embedded-content" data-secret="pwUXJp5Sfs"><a href="https://gizmodo.com.au/2016/07/new-cancer-therapy-leaves-three-dead/">New Cancer Therapy Leaves Three Dead</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://gizmodo.com.au/2016/07/new-cancer-therapy-leaves-three-dead/embed/#?secret=pwUXJp5Sfs" width="600" height="338" title="“New Cancer Therapy Leaves Three Dead” — Gizmodo Australia" data-secret="pwUXJp5Sfs" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
https://gizmodo.com.au/wp-content/uploads/2016/07/09/z390xahxmwuakmbdlr0p.jpg?quality=75970546Clinical trials of a promising new therapy, in which white blood cells are reprogrammed to attack cancer cells, has resulted in the deaths of three patients. In response, the US Food and Drug Administration has ordered a temporary halt to the trial.